Announcement PDF Market Announcement 3 November 2020 Recce Pharmaceuticals Ltd (ASX: RCE) – Trading Halt Description The securities of Recce Pharmaceuticals Ltd (‘RCE’) will be placed in trading halt at the request of RCE, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Thursday, 5 November 2020 or when the announcement is released to the market. Issued by Sandra Wutete Senior Adviser, Listings Compliance (Perth) 3 November 2020 ASX Limited Market Announcement 1/1 ASX Customer Service Centre 131 279 | asx.com.au 3 November 2020 Sean Maloney Adviser, Listings Compliance (Perth) Level 40 Central Park 152 - 158 St George’s Terrace PERTH WA 6000 By email: tradinghaltsperth@asx.com.au Dear Sean Recce Pharmaceuticals Ltd (ASX:RCE) – Trading halt request Pursuant to ASX Listing Rule 17.1, Recce Pharmaceuticals Ltd ACN 124 849 065 (Company) requests a trading halt of the Company’s securities pending the release of an announcement relating to anti-viral testing results. The Company requests that the trading halt be effective immediately and remain in place until the earlier of the commencement of normal trading on Thursday, 5 November 2020 or the release of an announcement by the Company in relation to the results. The Company is not aware of any reason why the trading halt should not be granted. For any questions, please contact the undersigned on +61 2 8072 1400. Yours faithfully Alistair McKeough Company Secretary